Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             25 results found
no title author magazine year volume issue page(s) type
1 A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010) Takizawa, Kohei

24 2 p. 479-491
article
2 Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways Su, Beibei

24 2 p. 352-367
article
3 Assessment of diagnostic value of fluorescent lymphography-guided lymphadenectomy for gastric cancer Jung, Minoa K.

24 2 p. 515-525
article
4 Association of surgeon and hospital volume with postoperative mortality after total gastrectomy for gastric cancer: data from 71,307 Japanese patients collected from a nationwide web-based data entry system Iwatsuki, Masaaki

24 2 p. 526-534
article
5 Clinical outcomes of endoscopic resection for undifferentiated intramucosal early gastric cancer larger than 2 cm Yang, Hyo-Joon

24 2 p. 435-444
article
6 Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial Fujitani, Kazumasa

24 2 p. 477-478
article
7 Diagnostic performance in gastric cancer is higher using endocytoscopy with narrow-band imaging than using magnifying endoscopy with narrow-band imaging Horiuchi, Yusuke

24 2 p. 417-427
article
8 Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3) Kurokawa, Yukinori

24 2 p. 428-434
article
9 Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis Molinari, Chiara

24 2 p. 392-401
article
10 Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial Fujitani, Kazumasa

24 2 p. 467-476
article
11 Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer Kim, So-Woon

24 2 p. 327-340
article
12 External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit? Jimenez-Fonseca, Paula

24 2 p. 445-456
article
13 Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial Iwasaki, Yoshiaki

24 2 p. 492-502
article
14 Gastric cancer is highly prevalent in Lynch syndrome patients with atrophic gastritis Cho, Hourin

24 2 p. 283-291
article
15 Gastric equivalent of the ‘Holy Plane’ to standardize the surgical concept of stomach cancer to mesogastric excision: updating Jamieson and Dobson’s historic schema Shinohara, Hisashi

24 2 p. 273-282
article
16 Histological diversity and molecular characteristics in gastric cancer: relation of cancer stem cell-related molecules and receptor tyrosine kinase molecules to mixed histological type and more histological patterns Sentani, Kazuhiro

24 2 p. 368-381
article
17 MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancer Fujiya, Keiichi

24 2 p. 341-351
article
18 Molecular alterations in gastric cancer and the surrounding intestinal metaplastic mucosa: an analysis of isolated glands Sugimoto, Ryo

24 2 p. 382-391
article
19 Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer Yamasaki, Makoto

24 2 p. 535-543
article
20 Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma Zheng, Hualong

24 2 p. 503-514
article
21 Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors Kim, Yeun-Yoon

24 2 p. 457-466
article
22 Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation Kim, Hee Jin

24 2 p. 302-313
article
23 SHARPIN stabilizes β-catenin through a linear ubiquitination-independent manner to support gastric tumorigenesis Zhang, Liang

24 2 p. 402-416
article
24 The potential role of nontyphoidal salmonellosis in gastric cancer: a nationwide matched cohort study Chang, Renin

24 2 p. 292-301
article
25 Tumor suppressor ATP4B serve as a promising biomarker for worsening of gastric atrophy and poor differentiation Pan, Yuanming

24 2 p. 314-326
article
                             25 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands